Investor

Edmond de Rothschild Venture Capital

Last cheque observed Jun 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries ASeries C

Cheques on record
0%of best year0cheques in 12 months, 54 on record
Since the last cheque4141days00hrs00min00sec
Median round$20MRounds led0 of 54Sole investor4 roundsExits7 from the portfolioMostly inFrance, 36%
Pitch Edmond de Rothschild Venture Capital

Edmond de Rothschild Venture Capital highlights

  1. 01

    54 rounds on record

  2. 02

    Mostly Series B and Series A: 54% of its rounds

  3. 03

    Sole investor in 4 rounds, median $3.0M

  4. 04

    7 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first54 appearances

  1. 2015

    3 rounds

  2. Jun
    Autonomic TechnologiesSeries D · US$43MWith 7 others
  3. May
    Autonomic TechnologiesSeries D · US$38MWith 4 others
  4. Jan
    GenkyotexSeries D · CH$21MWith 5 others
  5. 2014

    5 rounds

  6. Nov
    FinsecurVenture · PT$31MWith 1 other
  7. Sept
    PoxelSeries B · FR$14MWith 1 other
  8. May
    Chase PharmaceuticalsSeries B · US$21MWith 2 others
  9. Mar
    Axonics Modulation TechnologiesSeries A · US$33MWith 2 others
  10. Mar
    InotremSeries A · FR$23MWith 1 other
  11. 2013

    7 rounds

  12. Dec
    CovagenSeries B · CH · pehub.com$47MWith 7 others
  13. Jul
    JenaValve TechnologySeries C · DE · finsmes.com$63MWith 7 others
  14. Jul
    OncoEthixSeries B · CH · finsmes.com$19MWith 3 others
  15. Jun
    ComplixSeries B · BE · prnewswire.com$15MWith 7 others
  16. Apr
    GenticelSeries D · FR · finsmes.com$24MWith 4 others
  17. Apr
    Allecra TherapeuticsSeries A · FR · finance.yahoo.com$20MWith 2 others
  18. Jan
    TurbocoatingVenture · IT · finsmes.com$26MWith 2 others
  19. 2012

    4 rounds

  20. Dec
    Regado BiosciencesSeries E · US · regadobio.investorroom.com$51MWith 8 others
  21. Nov
    EndosenseSeries C · CH · finsmes.com$40MWith 7 others
  22. Jul
    GenkyotexSeries C · CH · finance.yahoo.com$26MWith 3 others
  23. Jan
    ProbiodrugVenture · DE · finsmes.com$19MWith 5 others
  24. 2011

    4 rounds

  25. Aug
    Vessix VascularSeries B · US · finsmes.com$23MWith 3 others
  26. Jun
    SapiensSeries A · DE · cisionwire.com$19MWith 2 others
  27. May
    GenkyotexSeries C · CH · reuters.com$20MWith 4 others
  28. Feb
    CellNovoSeries B · GB · cellnovo.com$48MWith 8 others
  29. 2010

    9 rounds

  30. Nov
    SuperSonic ImagineSeries C · FR · businesswire.com$45MWith 7 others
  31. Nov
    CovagenSeries A · CH · covagen.com$6.3MWith 4 others
  32. Sept
    Garden PriceVenture · FR · finsmes.com$2.7MSole investor
  33. Aug
    PoxelSeries A · FR · onbiovc.com$20MWith 3 others
  34. Jul
    ImplanetSeries D · FR · onbiovc.com$10MWith 2 others
  35. Apr
    ImplanetSeries C · FR$11MWith 4 others
  36. Apr
    GenticelSeries C · FR · onbiovc.com$18MWith 3 others
  37. Feb
    PDC BiotechSeries A · AT · onbiovc.com$5.5MWith 1 other
  38. Jan
    SmileVenture · FR · finsmes.com$3.6MSole investor
  39. 2009

    6 rounds

  40. Dec
    Regado BiosciencesSeries D · US · regadobio.com$40MWith 5 others
  41. Nov
    ProbiodrugSeries B · DE · probiodrug.de$54MWith 7 others
  42. Oct
    EndosenseSeries B · CH · onbiovc.com$36MWith 6 others
  43. Sept
    Santen PharmaceuticalSeries D$22MWith 6 others
  44. Jun
    ImplanetSeries B · FR$13MWith 3 others
  45. Mar
    GlycoVaxynSeries B · CH · bio-medicine.org$21MWith 2 others
  46. 2008

    2 rounds

  47. Oct
    SuperSonic ImagineSeries B · FR$26MWith 4 others
  48. Apr
    AJ TechSeries A · FR · fusacq.com$1.3MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed7 in all

GlycoVaxynBought by GSK Venture Fund$190MFeb 2015
OncoEthixBought by Merck & Co.UndisclosedDec 2014
SapiensBought by Medtronic$200MAug 2014
CovagenBought by CilagUndisclosedAug 2014
EndosenseBought by St. Jude Medical$170MAug 2013
Vessix VascularBought by Boston Scientific$300MNov 2012
MeeVeeBought by LiveUniverseUndisclosedMay 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Edmond de Rothschild Venture Capital. A count of rooms they were both in, not a relationship either has claimed.

Auriga PartnersVC firm12rounds togetherOmnesVC firm7rounds togetherBpifranceGovernment6rounds togetherWellington PartnersVC firm6rounds togetherGimvPrivate equity5rounds togetherIdinvest PartnersPrivate equity5rounds togetherNeoMedGrowth equity5rounds togetherMP Healthcare Venture ManagementCorporate VC4rounds togetherNovartis Venture FundCorporate VC4rounds togetherSofinnova PartnersVC firm4rounds togetherVI PartnersVC firm4rounds together123VentureVC firm3rounds together

Quick answers about Edmond de Rothschild Venture Capital

What does Edmond de Rothschild Venture Capital invest in?

Edmond de Rothschild Venture Capital invests most often at Series B and Series A (54% of the rounds on record).

How active is Edmond de Rothschild Venture Capital?

54 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2015.

How big are Edmond de Rothschild Venture Capital's cheques?

The median round it joins is $20M.

Does Edmond de Rothschild Venture Capital lead rounds?

Rarely, if at all: none of its 54 investments on record names it as the lead.

Where does Edmond de Rothschild Venture Capital invest?

Most of the companies it backs are in France (36%), Switzerland (23%) and the United States (18%).

Is Edmond de Rothschild Venture Capital investing now?

No investments in the last 12 months; the latest was in Jun 2015.

Who does Edmond de Rothschild Venture Capital invest alongside?

Most often Auriga Partners (12 rounds together), Omnes (7 rounds together) and Bpifrance (6 rounds together).

What kind of investor is Edmond de Rothschild Venture Capital?

Edmond de Rothschild Venture Capital is a growth equity firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it